- $6.90bn
- $15.36bn
- $5.72bn
- 56
- 87
- 85
- 89
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,117 | 6,146 | 6,895 | 6,049 | 5,716 |
Cost of Revenue | |||||
Gross Profit | 4,224 | 4,198 | 4,745 | 4,163 | 3,891 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5,309 | 5,225 | 5,106 | 4,731 | 6,151 |
Operating Profit | 808 | 920 | 1,788 | 1,318 | -435 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 973 | 1,069 | 2,501 | 1,248 | -238 |
Provision for Income Taxes | |||||
Net Income After Taxes | 738 | 807 | 1,969 | 926 | -168 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 688 | 762 | 1,630 | 921 | -96.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 565 | 525 | 1,393 | 684 | -334 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.44 | 1.98 | 2.85 | 1.52 | 1.11 |
Dividends per Share |